Lahey Clinic Hospital Inc.
- Type
- Teaching hospital
- Where
- Burlington, MA
- Medicare CCN
- 220171
- Received
- $601,497 in 124 records, 2020 ($362,382 general, $239,115 research)
- Source
- CMS Open Payments search ↗
On this site
- Nonprofit contractor: LAHEY CLINIC HOSPITAL Fuzzy (name and state)
- Nonprofit: LAHEY CLINIC HOSPITAL INC Fuzzy (name and state)
- Trademark owner: Lahey Clinic Hospital, Inc. Fuzzy (name and state)
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2020 | General payment | 64 | $362,382 |
| 2020 | Research payment | 60 | $239,115 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Intuitive Surgical, Inc. | 20 | $113,520 | 2020 |
| CARDIVA MEDICAL, INC. | 2 | $88,883 | 2020 |
| Intercept Pharmaceuticals, Inc. | 20 | $86,998 | 2020 |
| Linvatec Corporation | 1 | $50,061 | 2020 |
| Abbott Laboratories | 5 | $47,671 | 2020 |
| Procept Biorobotics Corporation | 1 | $43,751 | 2020 |
| Stryker Corporation | 5 | $36,476 | 2020 |
| Olympus America Inc. | 2 | $27,752 | 2020 |
| Smith+Nephew, Inc. | 25 | $20,401 | 2020 |
| Covidien LP | 2 | $20,000 | 2020 |
| CSL Behring | 12 | $16,668 | 2020 |
| AngioDynamics, Inc. | 1 | $13,000 | 2020 |
| INSTRUMENTATION LABORATORY COMPANY | 1 | $11,670 | 2020 |
| Intuitive Surgical Operations, Inc. | 4 | $8,450 | 2020 |
| Premia Spine, Ltd. | 4 | $5,080 | 2020 |
| Merck Sharp & Dohme LLC | 12 | $2,761 | 2020 |
| Janssen Pharmaceuticals, Inc | 1 | $1,500 | 2020 |
| Alexion Pharmaceuticals, Inc. | 1 | $1,500 | 2020 |
| AstraZeneca Pharmaceuticals LP | 1 | $1,500 | 2020 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $1,500 | 2020 |
| Cardiovascular Systems Inc. | 2 | $1,350 | 2020 |
| Genentech USA, Inc. | 1 | $1,000 | 2020 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Research payment | 60 | $239,115 |
| Education | 25 | $196,612 |
| Grant | 6 | $103,061 |
| Gift | 27 | $27,958 |
| Charitable Contribution | 1 | $27,748 |
| Space rental or facility fees (teaching hospital only) | 5 | $7,000 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2020-12-31 | Intuitive Surgical, Inc. | $14,880 | Education | In-kind items and services | Da Vinci Surgical System Device, SURGERY | 2020 | |
| 2020-12-31 | AngioDynamics, Inc. | $13,000 | Education | In-kind items and services | Solero Device, Oncology Surgery | 2020 | |
| 2020-12-31 | Stryker Corporation | $7,554 | Gift | In-kind items and services | TRURIZE Device, PATIENT CARE - PC | 2020 | |
| 2020-12-31 | Intuitive Surgical, Inc. | $5,000 | Education | In-kind items and services | Da Vinci Surgical System Device, SURGERY | 2020 | |
| 2020-12-31 | Intuitive Surgical, Inc. | $3,000 | Education | In-kind items and services | Da Vinci Surgical System Device, SURGERY | 2020 | |
| 2020-12-31 | Merck Sharp & Dohme LLC | $2,596 | Research payment | In-kind items and services | MK-6482 Drug, ONCOLOGY | An Open-label, Randomized, Phase 3 Study of MK-6482 in Combination with Lenvatinib MK-7902 vs Cabozantinib for Second-li | 2020 |
| 2020-12-31 | Intuitive Surgical, Inc. | $2,500 | Education | In-kind items and services | Da Vinci Surgical System Device, SURGERY | 2020 | |
| 2020-12-24 | Intercept Pharmaceuticals, Inc. | $3,652 | Research payment | Cash or cash equivalent | 1009742 | 2020 | |
| 2020-12-22 | CSL Behring | $4,793 | Research payment | Cash or cash equivalent | A Phase 2, Multicenter, Double Blind, Randomized, Placebo-Controlled Study to Evaluate CSL312 in Coronavirus Disease 201 | 2020 | |
| 2020-12-16 | Intuitive Surgical, Inc. | $2,000 | Education | Cash or cash equivalent | Da Vinci Surgical System Device, SURGERY | 2020 | |
| 2020-11-19 | Intercept Pharmaceuticals, Inc. | $5,269 | Research payment | Cash or cash equivalent | 1009742 | 2020 | |
| 2020-11-19 | Stryker Corporation | $675 | Research payment | Cash or cash equivalent | SURPASS Device, FLOW DIVERTER | EVOLVE | 2020 |
| 2020-11-19 | CSL Behring | $337 | Research payment | Cash or cash equivalent | A Phase 2, Multicenter, Double Blind, Randomized, Placebo-Controlled Study to Evaluate CSL312 in Coronavirus Disease 201 | 2020 | |
| 2020-11-18 | Intuitive Surgical, Inc. | $2,000 | Education | Cash or cash equivalent | Da Vinci Surgical System Device, SURGERY | 2020 | |
| 2020-11-16 | Covidien LP | $10,000 | Grant | Cash or cash equivalent | 2020 | ||
| 2020-11-12 | CSL Behring | $7,500 | Research payment | Cash or cash equivalent | A Phase 2, Multicenter, Double Blind, Randomized, Placebo-Controlled Study to Evaluate CSL312 in Coronavirus Disease 201 | 2020 | |
| 2020-11-12 | CSL Behring | $2,000 | Research payment | Cash or cash equivalent | A Phase 2, Multicenter, Double Blind, Randomized, Placebo-Controlled Study to Evaluate CSL312 in Coronavirus Disease 201 | 2020 | |
| 2020-11-12 | CSL Behring | $900 | Research payment | Cash or cash equivalent | A Phase 2, Multicenter, Double Blind, Randomized, Placebo-Controlled Study to Evaluate CSL312 in Coronavirus Disease 201 | 2020 | |
| 2020-11-12 | CSL Behring | $275 | Research payment | Cash or cash equivalent | A Phase 2, Multicenter, Double Blind, Randomized, Placebo-Controlled Study to Evaluate CSL312 in Coronavirus Disease 201 | 2020 | |
| 2020-11-04 | Intuitive Surgical, Inc. | $4,000 | Education | Cash or cash equivalent | Da Vinci Surgical System Device, SURGERY | 2020 | |
| 2020-10-29 | Intercept Pharmaceuticals, Inc. | $16,089 | Research payment | Cash or cash equivalent | 1009742 | 2020 | |
| 2020-10-29 | Cardiovascular Systems Inc. | $675 | Research payment | Cash or cash equivalent | Coronary Orbital Atherectomy System Device, Atherectomy Device | ECLIPSE | 2020 |
| 2020-10-27 | Janssen Pharmaceuticals, Inc | $1,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | XARELTO Drug, Cardiovascular & Metabolism | 2020 | |
| 2020-10-22 | CARDIVA MEDICAL, INC. | $36,060 | Research payment | Cash or cash equivalent | Vascular Closure Device Device, Vascular Closure | AMBULATE VASCADE MVP Same Day Discharge Retrospective Registry | 2020 |
| 2020-10-07 | Intuitive Surgical, Inc. | $4,000 | Education | Cash or cash equivalent | Da Vinci Surgical System Device, SURGERY | 2020 | |
| 2020-10-06 | AstraZeneca Pharmaceuticals LP | $1,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | LOKELMA Drug, Cardiovascular and Metabolism | 2020 | |
| 2020-10-01 | Stryker Corporation | $8,200 | Research payment | Cash or cash equivalent | SURPASS Device, FLOW DIVERTER | EVOLVE | 2020 |
| 2020-09-30 | Intuitive Surgical, Inc. | $14,880 | Education | In-kind items and services | Da Vinci Surgical System Device, SURGERY | 2020 | |
| 2020-09-30 | Intuitive Surgical, Inc. | $5,000 | Education | In-kind items and services | Da Vinci Surgical System Device, SURGERY | 2020 | |
| 2020-09-30 | Intuitive Surgical, Inc. | $3,000 | Education | In-kind items and services | Da Vinci Surgical System Device, SURGERY | 2020 | |
| 2020-09-30 | Intuitive Surgical, Inc. | $2,500 | Education | In-kind items and services | Da Vinci Surgical System Device, SURGERY | 2020 | |
| 2020-09-24 | Intercept Pharmaceuticals, Inc. | $6,212 | Research payment | Cash or cash equivalent | 1009742 | 2020 | |
| 2020-09-08 | Merck Sharp & Dohme LLC | $76 | Research payment | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | PEMBROLIZUMAB IN MUSCLE INVASIVE AND LOCALLY ADVANCED UROTHELIAL CARCINOMA AMBASSADOR | 2020 |
| 2020-09-08 | Merck Sharp & Dohme LLC | $35 | Research payment | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | PEMBROLIZUMAB IN MUSCLE INVASIVE AND LOCALLY ADVANCED UROTHELIAL CARCINOMA AMBASSADOR | 2020 |
| 2020-09-08 | Merck Sharp & Dohme LLC | $30 | Research payment | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | PEMBROLIZUMAB IN MUSCLE INVASIVE AND LOCALLY ADVANCED UROTHELIAL CARCINOMA AMBASSADOR | 2020 |
| 2020-09-08 | Merck Sharp & Dohme LLC | $4 | Research payment | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | PEMBROLIZUMAB IN MUSCLE INVASIVE AND LOCALLY ADVANCED UROTHELIAL CARCINOMA AMBASSADOR | 2020 |
| 2020-09-08 | Merck Sharp & Dohme LLC | $4 | Research payment | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | PEMBROLIZUMAB IN MUSCLE INVASIVE AND LOCALLY ADVANCED UROTHELIAL CARCINOMA AMBASSADOR | 2020 |
| 2020-09-08 | Merck Sharp & Dohme LLC | $3 | Research payment | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | PEMBROLIZUMAB IN MUSCLE INVASIVE AND LOCALLY ADVANCED UROTHELIAL CARCINOMA AMBASSADOR | 2020 |
| 2020-09-08 | Merck Sharp & Dohme LLC | $2 | Research payment | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | PEMBROLIZUMAB IN MUSCLE INVASIVE AND LOCALLY ADVANCED UROTHELIAL CARCINOMA AMBASSADOR | 2020 |
| 2020-09-08 | Merck Sharp & Dohme LLC | $2 | Research payment | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | PEMBROLIZUMAB IN MUSCLE INVASIVE AND LOCALLY ADVANCED UROTHELIAL CARCINOMA AMBASSADOR | 2020 |
| 2020-09-08 | Merck Sharp & Dohme LLC | $1 | Research payment | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | PEMBROLIZUMAB IN MUSCLE INVASIVE AND LOCALLY ADVANCED UROTHELIAL CARCINOMA AMBASSADOR | 2020 |
| 2020-09-08 | Merck Sharp & Dohme LLC | $1 | Research payment | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | PEMBROLIZUMAB IN MUSCLE INVASIVE AND LOCALLY ADVANCED UROTHELIAL CARCINOMA AMBASSADOR | 2020 |
| 2020-09-08 | Merck Sharp & Dohme LLC | $0 | Research payment | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | PEMBROLIZUMAB IN MUSCLE INVASIVE AND LOCALLY ADVANCED UROTHELIAL CARCINOMA AMBASSADOR | 2020 |
| 2020-09-04 | Intuitive Surgical Operations, Inc. | $2,875 | Research payment | Cash or cash equivalent | Da Vinci Surgical System Device, SURGERY | A prospective, evaluation of a robotic endoscope for the da Vinci Xi Surgical System | 2020 |
| 2020-09-04 | Intuitive Surgical Operations, Inc. | $1,350 | Research payment | Cash or cash equivalent | Da Vinci Surgical System Device, SURGERY | A prospective, evaluation of a robotic endoscope for the da Vinci Xi Surgical System | 2020 |
| 2020-09-03 | Premia Spine, Ltd. | $3,097 | Research payment | Cash or cash equivalent | TOPS | A Clinical Study to Assess the Safety and Effectiveness of the Premia Spine TOPS System | 2020 |
| 2020-09-01 | Alexion Pharmaceuticals, Inc. | $1,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2020 | ||
| 2020-08-27 | Intercept Pharmaceuticals, Inc. | $6,003 | Research payment | Cash or cash equivalent | 1009742 | 2020 | |
| 2020-08-13 | Intercept Pharmaceuticals, Inc. | $539 | Research payment | Cash or cash equivalent | 1009742 | 2020 | |
| 2020-08-13 | Intercept Pharmaceuticals, Inc. | $337 | Research payment | Cash or cash equivalent | 1009742 | 2020 | |
| 2020-07-30 | Intercept Pharmaceuticals, Inc. | $6,621 | Research payment | Cash or cash equivalent | 1009742 | 2020 | |
| 2020-07-29 | CARDIVA MEDICAL, INC. | $52,823 | Research payment | Cash or cash equivalent | Vascular Closure Device Device, Vascular Closure | AMBULATE Same Day Discharge Registry | 2020 |
| 2020-07-10 | CSL Behring | $352 | Research payment | In-kind items and services | A Phase 2, Multicenter, Double Blind, Randomized, Placebo-Controlled Study to Evaluate CSL312 in Coronavirus Disease 201 | 2020 | |
| 2020-07-10 | CSL Behring | $174 | Research payment | In-kind items and services | A Phase 2, Multicenter, Double Blind, Randomized, Placebo-Controlled Study to Evaluate CSL312 in Coronavirus Disease 201 | 2020 | |
| 2020-07-10 | CSL Behring | $173 | Research payment | In-kind items and services | A Phase 2, Multicenter, Double Blind, Randomized, Placebo-Controlled Study to Evaluate CSL312 in Coronavirus Disease 201 | 2020 | |
| 2020-07-10 | CSL Behring | $100 | Research payment | In-kind items and services | A Phase 2, Multicenter, Double Blind, Randomized, Placebo-Controlled Study to Evaluate CSL312 in Coronavirus Disease 201 | 2020 | |
| 2020-07-10 | CSL Behring | $55 | Research payment | In-kind items and services | A Phase 2, Multicenter, Double Blind, Randomized, Placebo-Controlled Study to Evaluate CSL312 in Coronavirus Disease 201 | 2020 | |
| 2020-07-10 | CSL Behring | $9 | Research payment | In-kind items and services | A Phase 2, Multicenter, Double Blind, Randomized, Placebo-Controlled Study to Evaluate CSL312 in Coronavirus Disease 201 | 2020 | |
| 2020-07-09 | Intercept Pharmaceuticals, Inc. | $2,383 | Research payment | Cash or cash equivalent | 1009742 | 2020 | |
| 2020-07-06 | Premia Spine, Ltd. | $890 | Research payment | Cash or cash equivalent | TOPS | A Clinical Study to Assess the Safety and Effectiveness of the Premia Spine TOPS System | 2020 |
| 2020-06-30 | Intuitive Surgical, Inc. | $14,880 | Education | In-kind items and services | Da Vinci Surgical System Device, SURGERY | 2020 | |
| 2020-06-30 | Intuitive Surgical, Inc. | $5,000 | Education | In-kind items and services | Da Vinci Surgical System Device, SURGERY | 2020 | |
| 2020-06-30 | Intuitive Surgical, Inc. | $3,000 | Education | In-kind items and services | Da Vinci Surgical System Device, SURGERY | 2020 | |
| 2020-06-30 | Intuitive Surgical, Inc. | $2,500 | Education | In-kind items and services | Da Vinci Surgical System Device, SURGERY | 2020 | |
| 2020-06-04 | Intercept Pharmaceuticals, Inc. | $4,285 | Research payment | Cash or cash equivalent | OCALIVA Drug, HEPATOLOGY GASTROENTEROLOGY | 1009742 | 2020 |
| 2020-06-04 | Premia Spine, Ltd. | $202 | Research payment | Cash or cash equivalent | TOPS | A Clinical Study to Assess the Safety and Effectiveness of the Premia Spine TOPS System | 2020 |
| 2020-05-28 | Abbott Laboratories | $30,000 | Grant | Cash or cash equivalent | 2020 | ||
| 2020-05-28 | Abbott Laboratories | $1,500 | Grant | Cash or cash equivalent | Assurity Pacemaker Device, Cardiac Arrhythmias and Heart Failure | 2020 | |
| 2020-05-28 | Abbott Laboratories | $1,500 | Grant | Cash or cash equivalent | TactiCath SE Device, Cardiac Arrhythmias and Heart Failure | 2020 | |
| 2020-05-15 | Covidien LP | $10,000 | Grant | Cash or cash equivalent | 2020 | ||
| 2020-05-07 | Linvatec Corporation | $50,061 | Grant | In-kind items and services | 2DHD CAMERA HEADS Device, ORTHOPEDIC SURGERY | 2020 | |
| 2020-05-07 | Intercept Pharmaceuticals, Inc. | $5,190 | Research payment | Cash or cash equivalent | OCALIVA Drug, HEPATOLOGY GASTROENTEROLOGY | 1009742 | 2020 |
| 2020-04-17 | Intuitive Surgical Operations, Inc. | $2,875 | Research payment | Cash or cash equivalent | Da Vinci Surgical System Device, SURGERY | A prospective, evaluation of a robotic endoscope for the da Vinci Xi Surgical System | 2020 |
| 2020-04-17 | Intuitive Surgical Operations, Inc. | $1,350 | Research payment | Cash or cash equivalent | Da Vinci Surgical System Device, SURGERY | A prospective, evaluation of a robotic endoscope for the da Vinci Xi Surgical System | 2020 |
| 2020-04-16 | Smith+Nephew, Inc. | $4,007 | Gift | In-kind items and services | Video Accessories Device, Sports Med Visualization | 2020 | |
| 2020-04-16 | Smith+Nephew, Inc. | $1,432 | Gift | In-kind items and services | LENS 4K Device, Sports Med Visualization | 2020 | |
| 2020-04-16 | Smith+Nephew, Inc. | $583 | Gift | In-kind items and services | Other VideoArthroscopes Device, Sports Med Visualization | 2020 | |
| 2020-04-16 | Smith+Nephew, Inc. | $511 | Gift | In-kind items and services | Arthroscopic Cannulas & Trocars Device, Sports Med Visualization | 2020 | |
| 2020-04-16 | Smith+Nephew, Inc. | $511 | Gift | In-kind items and services | Arthroscopic Cannulas & Trocars Device, Sports Med Visualization | 2020 | |
| 2020-04-16 | Smith+Nephew, Inc. | $218 | Gift | In-kind items and services | Other VideoArthroscopes Device, Sports Med Visualization | 2020 | |
| 2020-04-15 | Olympus America Inc. | $27,748 | Charitable Contribution | In-kind items and services | BF Videoscopes Device, Medical | 2020 | |
| 2020-04-12 | Smith+Nephew, Inc. | $1,477 | Gift | In-kind items and services | LENS 4K Device, Sports Med Visualization | 2020 | |
| 2020-04-12 | Smith+Nephew, Inc. | $1,477 | Gift | In-kind items and services | LENS 4K Device, Sports Med Visualization | 2020 | |
| 2020-04-12 | Smith+Nephew, Inc. | $1,477 | Gift | In-kind items and services | LENS 4K Device, Sports Med Visualization | 2020 | |
| 2020-04-12 | Smith+Nephew, Inc. | $1,387 | Gift | In-kind items and services | LENS 4K Device, Sports Med Visualization | 2020 | |
| 2020-04-12 | Smith+Nephew, Inc. | $1,387 | Gift | In-kind items and services | LENS 4K Device, Sports Med Visualization | 2020 | |
| 2020-04-12 | Smith+Nephew, Inc. | $1,139 | Gift | In-kind items and services | LENS 4K Device, Sports Med Visualization | 2020 | |
| 2020-04-12 | Smith+Nephew, Inc. | $1,056 | Gift | In-kind items and services | LENS 4K Device, Sports Med Visualization | 2020 | |
| 2020-04-12 | Smith+Nephew, Inc. | $592 | Gift | In-kind items and services | Other VideoArthroscopes Device, Sports Med Visualization | 2020 | |
| 2020-04-12 | Smith+Nephew, Inc. | $592 | Gift | In-kind items and services | Other VideoArthroscopes Device, Sports Med Visualization | 2020 | |
| 2020-04-12 | Smith+Nephew, Inc. | $310 | Gift | In-kind items and services | Other VideoArthroscopes Device, Sports Med Visualization | 2020 | |
| 2020-04-12 | Smith+Nephew, Inc. | $301 | Gift | In-kind items and services | Other VideoArthroscopes Device, Sports Med Visualization | 2020 | |
| 2020-04-12 | Smith+Nephew, Inc. | $301 | Gift | In-kind items and services | Other VideoArthroscopes Device, Sports Med Visualization | 2020 | |
| 2020-04-12 | Smith+Nephew, Inc. | $247 | Gift | In-kind items and services | Other VideoArthroscopes Device, Sports Med Visualization | 2020 | |
| 2020-04-12 | Smith+Nephew, Inc. | $247 | Gift | In-kind items and services | Other VideoArthroscopes Device, Sports Med Visualization | 2020 | |
| 2020-04-12 | Smith+Nephew, Inc. | $247 | Gift | In-kind items and services | Other VideoArthroscopes Device, Sports Med Visualization | 2020 | |
| 2020-04-12 | Smith+Nephew, Inc. | $247 | Gift | In-kind items and services | Other VideoArthroscopes Device, Sports Med Visualization | 2020 | |
| 2020-04-12 | Smith+Nephew, Inc. | $227 | Gift | In-kind items and services | Other VideoArthroscopes Device, Sports Med Visualization | 2020 | |
| 2020-04-12 | Smith+Nephew, Inc. | $227 | Gift | In-kind items and services | Other VideoArthroscopes Device, Sports Med Visualization | 2020 | |
| 2020-04-12 | Smith+Nephew, Inc. | $191 | Gift | In-kind items and services | Other VideoArthroscopes Device, Sports Med Visualization | 2020 | |
| 2020-04-09 | Stryker Corporation | $12,028 | Research payment | Cash or cash equivalent | CITADEL Device, COIL | 2020 | |
| 2020-04-02 | INSTRUMENTATION LABORATORY COMPANY | $11,670 | Education | Cash or cash equivalent | 2020 | ||
| 2020-03-31 | Intuitive Surgical, Inc. | $14,880 | Education | In-kind items and services | Da Vinci Surgical System Device, SURGERY | 2020 | |
| 2020-03-31 | Intuitive Surgical, Inc. | $5,000 | Education | In-kind items and services | Da Vinci Surgical System Device, SURGERY | 2020 | |
| 2020-03-31 | Intuitive Surgical, Inc. | $3,000 | Education | In-kind items and services | Da Vinci Surgical System Device, SURGERY | 2020 | |
| 2020-03-31 | Intuitive Surgical, Inc. | $2,500 | Education | In-kind items and services | Da Vinci Surgical System Device, SURGERY | 2020 | |
| 2020-03-26 | Intercept Pharmaceuticals, Inc. | $11,287 | Research payment | Cash or cash equivalent | OCALIVA Drug, HEPATOLOGY GASTROENTEROLOGY | 1009742 | 2020 |
| 2020-03-19 | Stryker Corporation | $8,019 | Research payment | Cash or cash equivalent | CITADEL Device, COIL | 2020 | |
| 2020-03-19 | Intercept Pharmaceuticals, Inc. | $4,050 | Research payment | Cash or cash equivalent | OCALIVA Drug, HEPATOLOGY GASTROENTEROLOGY | 1009742 | 2020 |
| 2020-03-12 | Intercept Pharmaceuticals, Inc. | $9,235 | Research payment | Cash or cash equivalent | OCALIVA Drug, HEPATOLOGY GASTROENTEROLOGY | 1009742 | 2020 |
| 2020-03-12 | Intercept Pharmaceuticals, Inc. | $202 | Research payment | Cash or cash equivalent | OCALIVA Drug, HEPATOLOGY GASTROENTEROLOGY | 1009742 | 2020 |
| 2020-03-04 | Premia Spine, Ltd. | $890 | Research payment | Cash or cash equivalent | TOPS | A Clinical Study to Assess the Safety and Effectiveness of the Premia Spine TOPS System | 2020 |
| 2020-02-20 | Intercept Pharmaceuticals, Inc. | $337 | Research payment | Cash or cash equivalent | OCALIVA Drug, HEPATOLOGY GASTROENTEROLOGY | 1009742 | 2020 |
| 2020-02-13 | Intercept Pharmaceuticals, Inc. | $3,681 | Research payment | Cash or cash equivalent | OCALIVA Drug, HEPATOLOGY GASTROENTEROLOGY | 1009742 | 2020 |
| 2020-02-13 | Intercept Pharmaceuticals, Inc. | $337 | Research payment | Cash or cash equivalent | OCALIVA Drug, HEPATOLOGY GASTROENTEROLOGY | 1009742 | 2020 |
| 2020-02-07 | Abbott Laboratories | $7,335 | Education | In-kind items and services | Reagent Device, Diagnostics | 2020 | |
| 2020-02-03 | Abbott Laboratories | $7,335 | Education | In-kind items and services | Reagent Device, Diagnostics | 2020 | |
| 2020-01-30 | Cardiovascular Systems Inc. | $675 | Research payment | Cash or cash equivalent | Coronary Orbital Atherectomy System Device, Atherectomy Device | ECLIPSE | 2020 |
| 2020-01-28 | Olympus America Inc. | $3 | Gift | In-kind items and services | 2020 | ||
| 2020-01-23 | Boehringer Ingelheim Pharmaceuticals, Inc. | $1,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2020 | ||
| 2020-01-16 | Genentech USA, Inc. | $1,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Xolair Biological, Immunology | 2020 | |
| 2020-01-16 | Intercept Pharmaceuticals, Inc. | $337 | Research payment | Cash or cash equivalent | OCALIVA Drug, HEPATOLOGY GASTROENTEROLOGY | 1009742 | 2020 |
| 2020-01-09 | Intercept Pharmaceuticals, Inc. | $945 | Research payment | Cash or cash equivalent | OCALIVA Drug, HEPATOLOGY GASTROENTEROLOGY | 1009742 | 2020 |
| 2020-01-01 | Procept Biorobotics Corporation | $43,751 | Education | In-kind items and services | AquaBeam Robotic System Device, Urology | 2020 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Burlington, MA, county Middlesex County, MA, state Massachusetts; placed by its city name.
| Measure | Place (city or town) Burlington, MA | County Middlesex County, MA | State Massachusetts |
|---|---|---|---|
| Population B01003 | 26,274 | 1,638,365 | 7,044,056 |
| Population, 2020 census P1 | 26,377 | 1,632,002 | 7,029,917 |
| Median age B01002 | 45.9 | 38.9 | 40.0 |
| Under 18 B01001 | 17.1% | 19.5% | 19.4% |
| 65 and over B01001 | 21.9% | 16.3% | 17.9% |
| Households B11001 | 9,974 | 634,215 | 2,785,042 |
| Foreign born B05002 | 17.9% | 23.1% | 18.0% |
| Median household income B19013 | $146,436 | $130,847 | $103,960 |
| Median family income B19113 | $171,411 | $166,449 | $131,675 |
| Per capita income B19301 | $69,012 | $69,556 | $57,897 |
| Poverty rate B17001 | 5.9% | 7.7% | 10.0% |
| Unemployment rate B23025 | 4.4% | 4.4% | 5.2% |
| Civilian labor force B23025 | 14,841 | 946,989 | 3,911,446 |
| Mean commute (minutes) B08013 | 27.5 | 29.9 | 29.1 |
| Bachelor's degree or higher B15003 | 58.4% | 59.5% | 47.3% |
| Housing units B25001 | 10,371 | 664,267 | 3,030,406 |
| Owner-occupied B25003 | 74.2% | 61.3% | 62.5% |
| Renters B25003 | 25.8% | 38.7% | 37.5% |
| Median home value B25077 | $740,600 | $727,800 | $562,100 |
| Median gross rent B25064 | $2,718 | $2,201 | $1,762 |
| White, not Hispanic B03002 | 74.4% | 65.1% | 66.6% |
| Black B03002 | 1.8% | 4.7% | 6.4% |
| Hispanic or Latino B03002 | 5.0% | 9.3% | 13.3% |
| Asian B03002 | 14.5% | 13.6% | 7.3% |
| American Indian and Alaska Native B03002 | 0.0% | 0.1% | 0.1% |
Economy now FRED unemployment 4.3% in Sep 2026 (4.6% a year earlier); per capita personal income $98,700 in 2025, up 27% in five years (+2.3% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Burlington, MA.
Comments